Home / Knowledge Centre /

Adaptations and Solutions for Clinical Supply Chain Challenges

At the beginning of the year, the pandemic presented great challenges for existing clinical trials and continues to impact new trials as well.  So since then, what have we learned and how can we overcome these challenges?

This insightful video will show you how the industry’s leading IRT provider was able to pivot and adapt to keep trials up and running while implementing key adaptations in a purposeful way to new studies.

Learn how they are accomplishing shorter timelines and ensuring that future decentralized trials succeed.

You will learn:

  • Our challenging landscape – existing pipelines vs COVID-19 pipelines
  • IRT setting changes that can make a positive impact for supply chain and distribution strategies
  • New distribution approaches that can benefit your trial

View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Please complete this form to view the Video

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies